Innovative nanotechnologies in the diagnosis and treatment of myocardial infarction: new horizons and perspectives

Abstract

Nanotechnologies in the field of diagnosing and treating myocardial infarction represent a rapidly evolving area. Polymer nanoparticles demonstrate promising potential in enhancing diagnostic accuracy and therapeutic effectiveness, serving as tools for detecting biomarkers and stimulating heart cell regeneration. These innovative methods, based on microRNA, liposomes, and M2 macrophages, offer prospects for novel strategies in cardiovascular disease treatment. Such innovative approaches to delivering microRNA that stimulates heart cell regeneration have the potential to improve heart function post-infarction. Overall, research in polymer nanoparticles paves the way for further clinical studies aimed at developing innovative methods for diagnosing and treating myocardial infarction.